Join Now

Yearly Archives: 2022

PolarityTE Announces $8.0 Million Registered Direct and Private Placement Offerings Priced At-The-Market Under Nasdaq Rules

By Natalie Themm | Published June 6, 2022

PolarityTE announced that it has entered into securities purchase agreements with a single healthcare-focused institutional investor

Posted in BioUtah News | Tagged | Leave a comment

Civica Selects Profil as Clinical Trial Partner for Affordable Insulin Initiative

By Natalie Themm | Published June 6, 2022

Profil has conducted over 30 biosimilar insulin trials and is the leading clinical research organization for studies related to diabetes.

Posted in BioUtah News | Tagged | Leave a comment

Biomerics announces expansion in Ireland with a new facility in Galway

By Natalie Themm | Published May 31, 2022

BIOMERICS ANNOUNCES EXPANSION INTO IRELAND Expanding High-Performance Balloon Design & Development Capabilities in Galway

Posted in BioUtah News | Tagged | Leave a comment

Co-Diagnostics, Inc. Completes Principal Design of Test for Monkeypox Virus

By Natalie Themm | Published May 31, 2022

Co-Diagnostics announced that it has completed the principal design work of a PCR test for the monkeypox virus currently exhibiting a multi-country outbreak.

Posted in BioUtah News | Tagged , | Leave a comment

Invest Lithuania

By Denise Bell | Published May 26, 2022

BioUtah has established a partnership with Invest Lithuania, an arm of the Lithuanian government focused on developing life sciences in their country. The life sciences sector in Lithuania is regarded as one of the most highly developed in Central and Eastern Europe (CEE). The sector is driven by innovation and aims to become Europe’s next […]

Posted in Policy News | Leave a comment

Biomerics Announces Image Guided Intervention Division

By admin | Published May 26, 2022

SALT LAKE CITY, UTAH (Monday, May 2, 2022) – Biomerics, a leading vertically integrated contract manufacturer for the attractive interventional device market, announced the creation of a new division, Biomerics Image Guided Intervention (IGI). Biomerics’ IGI Division, headquartered in Salt Lake City, provides advanced image generation and processing technologies to enable real-time minimally invasive advanced […]

Posted in BioUtah News | Leave a comment

bioMérieux receives De Novo FDA Authorization for its BIOFIRE® Joint Infection (JI) Panel

By Natalie Themm | Published May 25, 2022

Marcy l’Étoile, France – bioMérieux, a world leader in the field of in vitro diagnostics, today announces that its BIOFIRE® Joint Infection (JI) Panel has received De Novo authorization from the US Food and Drug Administration (FDA). This panel tests for 31 pathogens implicated in most acute joint infections, and also includes 8 antimicrobial resistance (AMR) […]

Posted in BioUtah News | Tagged | Leave a comment

PolarityTE to Effectuate 1-for-25 Reverse Stock Split

By Natalie Themm | Published May 18, 2022

PolarityTE announced that the Company will effectuate a 1-for-25 reverse stock split of the Company’s issued and outstanding common stock.

Posted in BioUtah News | Tagged | Leave a comment

PolarityTE Reports First Quarter 2022 Financial Results and Provides Business Update

By Natalie Themm | Published May 16, 2022

PolarityTE provided a business update and reported financial results for the three-month period ended March 31, 2022.

Posted in BioUtah News | Tagged | Leave a comment

PolarityTE Announces FDA Regenerative Medicine Advanced Therapy Designation Granted to SkinTE®

By Natalie Themm | Published May 16, 2022

PolarityTE announced that the U.S. FDA granted a Regenerative Medicine Advanced Therapy (RMAT) designation to SkinTE under the Company’s open IND. 

Posted in BioUtah News | Tagged | Leave a comment

BioHive Takes the Stage at One Utah Summit

By Denise Bell | Published May 12, 2022

The BioHive community was featured prominently at the One Utah Summit held on May 10 at the Grand America Hotel in Salt Lake City. Speakers from the life sciences industry addressed the crowd on topics ranging from job creation and talent development to life-saving innovation and drug discovery. Tom Polen, CEO of BD, and Rob […]

Posted in BioUtah News, Industry News, Life Sciences Industry News, Utah's Life Sciences Companies | Leave a comment

Recursion Co-Founder and CEO, Chris Gibson, Awarded Governor’s Medal for Science and Technology

By Denise Bell | Published May 12, 2022

Recursion Co-founder and CEO, Chris Gibson, Ph.D., was honored at the One Utah Summit on May 10, receiving the Governor’s Medal for Science and Technology. Gov. Spencer Cox presented the award during the summit’s special recognition ceremony. The prestigious award commends the distinguished service, significant achievement, and positive economic impact of individuals to the state […]

Posted in BioUtah News, Industry News, Life Sciences Industry News, Utah's Life Sciences Companies | Leave a comment

A Special Thanks To Our Legacy and Platinum Elite Members